Xi Yu

1.0k total citations · 1 hit paper
43 papers, 747 citations indexed

About

Xi Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xi Yu has authored 43 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xi Yu's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Xi Yu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Xi Yu collaborates with scholars based in China, United States and Macao. Xi Yu's co-authors include Hongchen He, Xiao-Na Xiang, Siyi Zhu, Chengqi He, Yang Xu, Feng Qian, Boxing Su, Lang Yang, You‐Hong Cui and Xiu‐Wu Bian and has published in prestigious journals such as Scientific Reports, The American Journal of Sports Medicine and Archives of Biochemistry and Biophysics.

In The Last Decade

Xi Yu

43 papers receiving 738 citations

Hit Papers

Mesenchymal stromal cell-based therapy for cartilage rege... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Yu China 15 410 227 162 101 95 43 747
Maria Serena Roca Italy 14 457 1.1× 152 0.7× 184 1.1× 104 1.0× 38 0.4× 28 709
Carrie A. Franzen United States 13 819 2.0× 453 2.0× 193 1.2× 75 0.7× 60 0.6× 19 1.1k
Vijesh Kumar Yadav Taiwan 18 502 1.2× 310 1.4× 173 1.1× 147 1.5× 30 0.3× 41 814
Alessandro Colapietro Italy 17 370 0.9× 116 0.5× 262 1.6× 76 0.8× 32 0.3× 34 728
Lang‐Ming Chi Taiwan 20 512 1.2× 176 0.8× 172 1.1× 69 0.7× 29 0.3× 33 874
David Pocalyko United States 11 454 1.1× 190 0.8× 98 0.6× 58 0.6× 63 0.7× 25 748
Zhijun Xi China 17 437 1.1× 145 0.6× 145 0.9× 111 1.1× 41 0.4× 37 848
Carmen Griñán‐Lisón Spain 18 512 1.2× 318 1.4× 342 2.1× 77 0.8× 29 0.3× 39 969
Luke Miller United States 6 699 1.7× 500 2.2× 261 1.6× 114 1.1× 41 0.4× 8 963
Jiao Ji China 11 618 1.5× 238 1.0× 216 1.3× 103 1.0× 19 0.2× 23 1.0k

Countries citing papers authored by Xi Yu

Since Specialization
Citations

This map shows the geographic impact of Xi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Yu more than expected).

Fields of papers citing papers by Xi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Yu. The network helps show where Xi Yu may publish in the future.

Co-authorship network of co-authors of Xi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Yu. A scholar is included among the top collaborators of Xi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Yu. Xi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Xiao-Na, et al.. (2025). The Effect of Platelet-Rich Plasma on Synovial Fibrosis and Cartilage Degeneration in Knee Osteoarthritis. The American Journal of Sports Medicine. 53(6). 1428–1439. 1 indexed citations
2.
Yu, Xi, et al.. (2025). C7ORF41 Alleviates Ferroptosis Via the Keap1/Nrf2/HO-1 Axis in Endotoxin-Associated Acute Kidney Injury. Inflammation. 48(6). 4414–4427. 1 indexed citations
3.
Song, Chao, et al.. (2025). Bioinformatics revealed biomarkers for diagnosis in kidney stones. Frontiers in Genetics. 16. 1542840–1542840. 1 indexed citations
4.
Zhu, Lin, et al.. (2024). Polysaccharide from Asparagus officinalis activated macrophages through NLRP3 inflammasome based on RNA-seq analysis. Biomedicine & Pharmacotherapy. 181. 117729–117729. 3 indexed citations
5.
Yu, Xi, et al.. (2024). CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer. Journal of Cancer. 15(11). 3242–3253. 2 indexed citations
6.
Yu, Xi, et al.. (2023). Signatures and prognostic values of related immune targets in tongue cancer. Frontiers in Surgery. 9. 952389–952389. 4 indexed citations
7.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2023). Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 22(1). 74–74. 2 indexed citations
8.
Liu, Zelin, et al.. (2022). SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway. Cancer Cell International. 22(1). 127–127. 15 indexed citations
10.
Chen, Jialei, Xi Yu, & Xiang Zhang. (2021). Advances on biological functions of exosomal non‐coding RNAs in osteoarthritis. Cell Biochemistry and Function. 40(1). 49–59. 9 indexed citations
11.
Yu, Xi, et al.. (2021). Transcriptome study underling difference of milk yield during peak lactation of Kazakh horse. Journal of Equine Veterinary Science. 102. 103424–103424. 10 indexed citations
12.
Yuan, Ping, et al.. (2019). A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy. Frontiers in Chemistry. 7. 868–868. 8 indexed citations
13.
Li, Yali, Cailing Gan, Yange Zhang, et al.. (2019). Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis. Frontiers in Pharmacology. 10. 1195–1195. 36 indexed citations
14.
Gao, Tiantao, Xi Hu, Qian Lei, et al.. (2018). Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer Letters. 445. 11–23. 32 indexed citations
15.
Zheng, Hong, Jia-Ning Chen, Xi Yu, et al.. (2016). HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells. DNA and Cell Biology. 35(10). 622–627. 31 indexed citations
16.
Zhu, Yongxia, Tinghong Ye, Xi Yu, et al.. (2016). Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Scientific Reports. 6(1). 20253–20253. 64 indexed citations
17.
Ge, P. T., Xi Yu, Zicheng Wang, & Jian Lin. (2015). Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 16(9). 4071–4075. 6 indexed citations
18.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2014). Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 13(1). 206–206. 88 indexed citations
19.
Yang, Lang, Yi‐Fang Ping, Xi Yu, et al.. (2011). Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Letters. 310(1). 46–52. 65 indexed citations
20.
Chen, Xiao, Junping Liu, Bee Jen Tan, et al.. (2008). The C-terminus of PRK2/PKNγ is required for optimal activation by RhoA in a GTP-dependent manner. Archives of Biochemistry and Biophysics. 479(2). 170–178. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026